Show source-provided references
4. Nomura, Y., Okada, A., and Hanada, N. (2022). Future Prospective of Oral Microbiome Research. Appl. Sci., 12.
10.3390/app12010055 ↗8. Liu, H., Jie, Y., and Han, X. (2020). 181 Anlyasis of therapeutic effect and safty of PD-1 inhibitors in clinical treatment of oral and maxillofacial malignant tumors. J. ImmunoTherapy Cancer, 8.
10.1136/jitc-2020-SITC2020.0181 ↗11. Abedi, N., Sajadi-Javan, Z.S., Kouhi, M., Ansari, L., Khademi, A., and Ramakrishna, S. (2023). Antioxidant Materials in Oral and Maxillofacial Tissue Regeneration: A Narrative Review of the Literature. Antioxidants, 12.
10.3390/antiox12030594 ↗12. Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study
10.1177/0022034520908533 ↗16. Eid, A., Mancino, D., Rekab, M.S., Haikel, Y., and Kharouf, N. (2022). Effectiveness of Three Agents in Pulpotomy Treatment of Permanent Molars with Incomplete Root Development: A Randomized Controlled Trial. Healthcare, 10.
10.3390/healthcare10030431 ↗24. Influence of particle size and shape on their margination and wall-adhesion: Implications in drug delivery vehicle design across nano-to-micro scale
10.1039/C8NR04042G ↗25. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
10.2217/nnm.16.5 ↗26. Hanssen, A., Riebensahm, C., Mohme, M., Joosse, S.A., Velthaus, J.L., Berger, L.A., Bernreuther, C., Glatzel, M., Loges, S., and Lamszus, K. (2018). Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease. Cancers, 10.
10.3390/cancers10120527 ↗27. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy
10.1002/adma.202104779 ↗28. Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management
10.1002/advs.202004014 ↗29. Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer
10.1002/ijc.31108 ↗31. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors
10.1039/C4NR04853A ↗37. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties
10.2147/IJN.S189295 ↗40. Nanotechnology in dentistry: Prevention, diagnosis, and therapy
41. Antimicrobial and Anti-Inflammatory Activity of Chitosan–Alginate Nanoparticles: A Targeted Therapy for Cutaneous Pathogens
10.1038/jid.2012.399 ↗44. Lopez-Piriz, R., Sola-Linares, E., Rodriguez-Portugal, M., Malpica, B., Diaz-Guemes, I., Enciso, S., Esteban-Tejeda, L., Cabal, B., Granizo, J.J., and Moya, J.S. (2015). Evaluation in a Dog Model of Three Antimicrobial Glassy Coatings: Prevention of Bone Loss around Implants and Microbial Assessments. PLoS ONE, 10.
10.1371/journal.pone.0140374 ↗46. Antibacterial and remineralizing nanocomposite inhibit root caries biofilms and protect root dentin hardness at the margins
10.1016/j.jdent.2020.103344 ↗51. Corrigendum to “Understanding the role of gut microbes and probiotics in obesity: How far are we?” [Pharmacol. Res. 69 (2013) 144–155]
10.1016/j.phrs.2013.02.006 ↗55. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy
10.1038/s41401-022-00902-w ↗57. Ye, F., Zhu, Z.D., Gu, Y.C., Li, J., Zhu, W.L., and Guo, Y.W. (2018). Further New Diterpenoids as PTP1B Inhibitors from the Xisha Soft Coral Sinularia polydactyla. Mar. Drugs, 16.
10.3390/md16040103 ↗59. Saliva: An emerging biofluid for early detection of diseases
60. A highly sensitive uric acid electrochemical biosensor based on a nano-cube cuprous oxide/ferrocene/uricase modified glassy carbon electrode
10.1038/s41598-020-67394-8 ↗64. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer
10.1039/c0an00204f ↗65. In Situ Formation of Nanotheranostics to Overcome the Blood-Brain Barrier and Enhance Treatment of Orthotopic Glioma
10.1021/acsami.0c03873 ↗66. Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma
10.7150/ntno.39514 ↗67. Magnetic Nanoliposomes as in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics
10.1021/acsnano.6b06815 ↗68. Fatima, T., Khurshid, Z., Rehman, A., Imran, E., Srivastava, K.C., and Shrivastava, D. (2021). Gingival Crevicular Fluid (GCF): A Diagnostic Tool for the Detection of Periodontal Health and Diseases. Molecules, 26.
10.3390/molecules26051208 ↗69. Analysis of inorganic ions in gingival crevicular fluid as indicators of periodontal disease activity: A clinico-biochemical study
10.4103/0976-237X.91788 ↗74. Nanotechnology in dentistry: Present and future
75. Gold Nanorods Based Air Scanning Electron Microscopy and Diffusion Reflection Imaging for Mapping Tumor Margins in Squamous Cell Carcinoma
10.1021/acsnano.5b07114 ↗76. Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor
10.2147/IJN.S300125 ↗77. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences
10.1186/1479-5876-8-134 ↗79. Kang, T.H., Mao, C.P., He, L., Tsai, Y.C., Liu, K., La, V., Wu, T.C., and Hung, C.F. (2012). Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects. PLoS ONE, 7.
10.1371/journal.pone.0035141 ↗80. Wei, L., Wen, X.S., and Xian, C.J. (2021). Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways. Int. J. Mol. Sci., 22.
10.3390/ijms22179474 ↗83. Development of a multifunctional gold nanoplatform for combined chemo-photothermal therapy against oral cancer
10.2217/nnm-2019-0415 ↗85. Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma
10.1093/carcin/bgz177 ↗87. An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives
10.1111/odi.13088 ↗88. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence
10.1007/s12253-019-00606-3 ↗90. Sonaje, K., Tyagi, V., Chen, Y., and Kalia, Y.N. (2021). Iontosomes: Electroresponsive Liposomes for Topical Iontophoretic Delivery of Chemotherapeutics to the Buccal Mucosa. Pharmaceutics, 13.
10.3390/pharmaceutics13010088 ↗91. Evaluation of the antiapoptotic and anti-inflammatory properties of chitosan in methotrexate-induced oral mucositis in rats
10.1007/s11033-022-07158-x ↗93. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs
10.1016/j.ejps.2015.04.004 ↗96. Vascularized pulp regeneration via injecting simvastatin functionalized GelMA cryogel microspheres loaded with stem cells from human exfoliated deciduous teeth
10.1016/j.mtbio.2022.100209 ↗99. Semiconducting Polymer Nanoparticles with Intramolecular Motion-Induced Photothermy for Tumor Phototheranostics and Tooth Root Canal Therapy
10.1002/adma.202200179 ↗100. Novel endodontic sealer with dual strategies of dimethylaminohexadecyl methacrylate and nanoparticles of silver to inhibit root canal biofilms
10.1016/j.dental.2019.05.014 ↗